Literature DB >> 1842184

High-dose preoperative radiation and radical sphincter-preserving surgery for rectal cancer.

G Marks1, M Mohiuddin, A Eitan, L Masoni, J Rakinic.   

Abstract

To reduce local recurrence associated with rectal cancer and to extend the scope of anal sphincter preservation, a selective program of high-dose preoperative radiation therapy and sphincter-preserving surgery was initiated in 1976. High-energy photon therapy (40 to 60 Gy) was administered in doses of 1.8 to 2.5 Gy during a period of 4 1/2 to 6 weeks and followed in 4 to 6 weeks with curative sphincter-preserving surgery for clinicopathologically unfavorable and low rectal cancers. None of the 143 patients in the study died during the postoperative period. Fifteen (13%) of 117 patients followed up for at least 24 months experienced local recurrence. Acceptable sphincter function was retained in 130 patients (91%). Our program of high-dose preoperative radiation therapy and sphincter-preserving surgery for the treatment of high-risk cancers, including those in the distal third of the rectum, resulted in better-than-expected survival and control of local recurrence with acceptable morbidity and no mortality.

Entities:  

Mesh:

Year:  1991        PMID: 1842184     DOI: 10.1001/archsurg.1991.01410360108018

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

Review 1.  Intersphincteric Resection Pushing the Envelope for Sphincter Preservation.

Authors:  Quentin Denost; Eric Rullier
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

2.  Late anastomotic leakage after anal sphincter saving surgery for rectal cancer: is it different from early anastomotic leakage?

Authors:  Seung Yoon Yang; Yoon Dae Han; Min Soo Cho; Hyuk Hur; Byung Soh Min; Kang Young Lee; Nam Kyu Kim
Journal:  Int J Colorectal Dis       Date:  2020-05-05       Impact factor: 2.571

3.  Conservative surgery for low rectal carcinoma after high-dose radiation. Functional and oncologic results.

Authors:  P Rouanet; J M Fabre; J B Dubois; F Dravet; B Saint Aubert; J Pradel; M Ychou; C Solassol; H Pujol
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.